Publication

Integrating an ex vivo model into fibrosis research

Gore, E., 2019, [Groningen]: University of Groningen. 227 p.

Research output: ThesisThesis fully internal (DIV)

Copy link to clipboard

Documents

  • Title and contents

    Final publisher's version, 664 KB, PDF document

  • Chapter 1

    Final publisher's version, 563 KB, PDF document

  • Chapter 2

    Final publisher's version, 7.55 MB, PDF document

  • Chapter 3

    Final publisher's version, 5.4 MB, PDF document

  • Chapter 4

    Final publisher's version, 6.75 MB, PDF document

  • Chapter 5

    Final publisher's version, 5.17 MB, PDF document

  • Chapter 6

    Final publisher's version, 4.85 MB, PDF document

  • Chapter 7

    Final publisher's version, 1.58 MB, PDF document

  • Chapter 8

    Final publisher's version, 555 KB, PDF document

  • Chapter 9

    Final publisher's version, 735 KB, PDF document

  • Complete thesis

    Final publisher's version, 27.8 MB, PDF document

  • Propositions

    Final publisher's version, 358 KB, PDF document

  • Emilia Gore
Fibrosis, the tissue response to continuous injury and improper wound healing leading to excessive extracellular matrix deposition, is a progressive condition that can affect many organs and leads to high morbidity and mortality. Despite its high prevalence worldwide, no approved antifibrotic therapies exist.
Emilia Gore conducted her research on a model that could accelerate the development of an antifibrotic drug. The model is precision-cut tissue slices (PCTS), which preserves the cellular and architectural structure of an organ. The culture of PCTS induces a fibrogenic response, allowing the investigation of fibrosis initiation (culturing healthy tissue slices) and progression (culturing diseased tissue slices), together with fibrosis reversal (testing antifibrotic compounds).
In this thesis, Emilia advanced the understanding of mouse and human PCTS by exploring the biological changes during culture with an extensive transcriptional analysis. Additionally, she developed a model of non-alcoholic steatohepatitis (NASH) – fatty liver – by using PCTS from mouse models of this condition. PCTS replicated central features of NASH and the model proved suitable to evaluate possible treatments. She also explored the possibility of fibrosis treatment through the inhibition of a central fibrosis pathway, and described in her thesis a potential preclinical marker for advanced liver fibrosis.
The studies presented in this thesis reinforce the use of PCTS for fibrosis research.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Supervisors/Advisors
Award date12-Jul-2019
Place of Publication[Groningen]
Publisher
Print ISBNs978-94-034-1828-5
Electronic ISBNs978-94-034-1827-8
Publication statusPublished - 2019

Download statistics

No data available

ID: 86539762